Webinars on demand

The field of digital pathology (DP) continues to see ongoing innovation, growth and development.

In this webinar, the speakers will describe how they used multiplexed imaging and single-cell analysis to study the immune response to the SARS-CoV-2 virus across multiple organ systems.

Optimisation and validation of a multiplex immunofluorescence workflow, from staining to digital image analysis, ensures assay robustness and prepares this technology for deployment in clinical trial analysis and in routine diagnostics.

Microsatellite Instability (MSI)-High has been identified as a biomarker for immune checkpoint inhibitor therapy in cancers originating in different tissues.

An increasing number of clinical laboratories are using next generation sequencing (NGS) for the molecular characterization of cancer.

ArcherDX , now Invitae is a leading genomics company democratizing precision oncology.

Prostate cancer, the most frequently diagnosed cancer in 105 countries and the leading cause of death in 46 countries worldwide, is diagnosed by core needle biopsy.

clonoSEQ® Assay is a highly sensitive, specific, and standardized method for detecting and monitoring minimal residual disease (MRD).

Targeted NGS has been instrumental in driving our understanding of disease.

The Pathologist is delighted to introduce the Pathologists’ Assistants: Bridging the Gap Live Roundtable.

The use of genomic profiling for myeloid samples has accelerated in recent years due in part to increasing annotation of disease-associated biomarkers.

Region Skåne (Sweden) has implemented digital pathology in 4 labs across their enterprise.